Loading ...

Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m

(

)

ITN Protocol #:

ITN002AI

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study

Clinical Operations Manager

ITN Biologist

Study Personnel:

Protocol Chair

Patti Tosta ptosta@immunetolerance.org

Work:

415-353-4421

Protocol Chair

Kristina Harris, PhD

Work:

Admin Links

Shortcuts

ITN Documents

Links